Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
The Lancet(2)
International Journal of Epidemiology(1)
International Journal of Stroke(1)
Stroke(1)
Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study
ArticleAbstract: Background and Purpose: In thrombolysis-eligible patients with acute ischemic stroke, there is uncerPalabras claves:Blood pressure, Hypertension, intracranial hemorrhage, Ischemic strokeAutores:Anderson C.S., Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen G., Chen X., Delcourt C., Demchuk A.M., Donnan G.A., Durham A.C., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Luca Di Tanna G., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Sato S., Sharma V.K., Silva-Sieger F.A., Song L., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusContributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
ArticleAbstract: Background: Change in the prevalence of raised blood pressure could be due to both shifts in the entPalabras claves:Blood pressure, Global Health, Hypertension, Non-communicable disease, Population healthAutores:Abarca-Gómez L., Abdeen Z.A., Abu-Rmeileh N.M.E., Acosta-Cazares B., Adams R.J., Aekplakorn W., Afsana K., Agyemang C., Ahmad N.A., Ahmadvand A., Ahrens W., Ajlouni K., Akhtaeva N., Al-Raddadi R., Ali M.M., Ali O., Alkerwi A., Aly E., Amarapurkar D.N., Amouyel P., Amuzu A., Anderssen S.A., Ängquist L.H., Anjana R.M., Ansong D., Aounallah-Skhiri H., Araújo J., Ariansen I., Aris T., Arlappa N., Arveiler D., Aryal K.K., Aspelund T., Assah F.K., Assuncao M.C.F., Avdicová M., Azevedo A., Azizi F., Babu B.V., Bahijri S., Balakrishna N., Bamoshmoosh M., Banach M., Bandosz P., Banegas J.R., Barbagallo C.M., Barceló A., Barkat A., Barros M.V.G., Bata I., Batieha A.M., Batyrbek A., Baur L.A., Beaglehole R., Benet M., Bennett J.E., Benson L.S., Bentham J., Bernabe-Ortiz A., Bernotiene G., Bettiol H., Bhagyalaxmi A., Bharadwaj S., Bhargava S.K., Bi Y., Bikbov M., Bilano V., Bixby H., Bo Andersen L., Carrillo-Larco R.M., Chen Z., Cowan M.J., Danaei G., de Barros A.J.D., Di Cesare M., Djalalinia S., Ezzati M., Hajifathalian K., Hambleton I.R., Jackson R.T., Kengne A.P., Khang Y.H., Khatibzadeh S., Laxmaiah A., Liu J., Lugero C., Malekzadeh R., Neuhauser H.K., Peykari N., Riley L.M., Romdhane H.B., Salinas C.A.A., Silvana P. Donoso, Sorić M., Starc G., Stevens G.A., Sundström J., Taddei C., Woodward M., Zhang W.Z., Zhou B.Fuentes:scopusIntensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
ArticleAbstract: Background: Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic trePalabras claves:Autores:Arima H., Armenis M., Bai X., Baig M.A., Bath P.M.W., Benito D., Billot L., Blacklock N., Bousser M.G., Broderick J.P., Cao Y., Carcel C., Chalmers J., Chen G., Chen R., Chen X., Cong Y., Coutts S., Cui B., Delcourt C., Demchuk A.M., Deng H., Donnan G.A., Donnelly P., Durham A.C., Fuentes-Patarroyo S.X., Glass P., Gordon P., Guo Y., Hankey G.J., Haunton V., He R., Hirakawa Y., Huang Y., Ivanova E., Jenson K., Jia H., Kim J.S., Knight E., Kong L., Kumar N.N., Kunchok A., Lavados P.M., Levi C., Li Q., Lim J.Y., Lindley R.I., Liu L., Lv J., Malavera A., Manning L., Martins S.O., Minhas J.S., Mistri A., Monaghan H., Moullaali T.J., Naidu B., Octavio Marques Pontes-Neto, Odgers E., Olavarria V.V., Parsons M.W., Ricci S., Richtering S., Robinson T.G., S Anderson C., Sandercock P., Sanders E., Sato S., Scaria A., Sharma V.K., Silva-Sieger F.A., Simes R.J., Small S., Smith P., Song L., Stapf C., Tay N., Thang N.H., Thembani E., Tucker S., Vaghasiya R., Wang J.G., Wang X., Wardlaw J.M., Winters S., Wong K.S.L., Woodward M., Wu G., Xi Z., Yang J., Yoshimura S., You S., Zhang S., Zhao H., Zhu P.Fuentes:scopusWorldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
ArticleAbstract: Background Raised blood pressure is an important risk factor for cardiovascular diseases and chronicPalabras claves:Autores:Abarca-Gómez L., Abdeen Z.A., Abu-Rmeileh N.M.E., Acosta-Cazares B., Adams R.J., Aekplakorn W., Afsana K., Agyemang C., Ahmadvand A., Ahrens W., Al Woyatan R., Al-Raddadi R., Ali M.M., Alkerwi A., Aly E., Amouyel P., Amuzu A., Anderssen S.A., Ängquist L.H., Anjana R.M., Ansong D., Aounallah-Skhiri H., Araújo J., Ariansen I., Aris T., Arlappa N., Arveiler D., Aryal K.K., Assah F.K., Assuncao M.C.F., Avdicová M., Azevedo A., Azizi F., Babu B.V., Bahijri S., Balakrishna N., Bandosz P., Banegas J.R., Barbagallo C.M., Barceló A., Barkat A., Barros M.V.G., Bata I., Batieha A.M., Baur L.A., Beaglehole R., Benet M., Bennett J.E., Benson L.S., Bentham J., Bernabe-Ortiz A., Bernotiene G., Bettiol H., Bhagyalaxmi A., Bharadwaj S., Bhargava S.K., Bi Y., Bilano V., Bixby H., Bo Andersen L., Bovet P., Carrillo-Larco R.M., Cowan M.J., Danaei G., de Barros A.J.D., Di Cesare M., Djalalinia S., Elliott P., Ezzati M., Gu D., Hajifathalian K., Ikeda N., Jackson R.T., Joffres M., Kengne A.P., Khatibzadeh S., Laatikainen T., Lam T.H., Laxmaiah A., Liu J., Lu Y., Lugero C., Miranda J.J., Mondo C.K., Neuhauser H.K., Paciorek C.J., Peykari N., Rahim H.F.A., Riley L.M., Romdhane H.B., Salinas C.A.A., Silvana P. Donoso, Silvana Patricia Donoso Moscoso, Singh G.M., Smeeth L., Sorić M., Stevens G.A., Sundström J., Taddei C., Woodward M., Zhang W.Z., Zhou B.Fuentes:rraaescopusRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
ArticleAbstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogPalabras claves:Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysisAutores:Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.Fuentes:scopus